- Home
- JRI vs PACB Comparison
JRI vs PACB Comparison
Compare JRI & PACB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JRI
- PACB
- Stock Information
- Founded
- JRI 2012
- PACB 2000
- Country
- JRI United States
- PACB United States
- Employees
- JRI N/A
- PACB N/A
- Industry
- JRI Finance Companies
- PACB Biotechnology: Laboratory Analytical Instruments
- Sector
- JRI Finance
- PACB Industrials
- Exchange
- JRI Nasdaq
- PACB Nasdaq
- Market Cap
- JRI 358.6M
- PACB 364.2M
- IPO Year
- JRI N/A
- PACB 2010
- Fundamental
- Price
- JRI $13.54
- PACB $1.29
- Analyst Decision
- JRI
- PACB Buy
- Analyst Count
- JRI 0
- PACB 9
- Target Price
- JRI N/A
- PACB $2.06
- AVG Volume (30 Days)
- JRI 68.0K
- PACB 10.1M
- Earning Date
- JRI 01-01-0001
- PACB 08-06-2025
- Dividend Yield
- JRI 9.38%
- PACB N/A
- EPS Growth
- JRI N/A
- PACB N/A
- EPS
- JRI N/A
- PACB N/A
- Revenue
- JRI N/A
- PACB $152,357,000.00
- Revenue This Year
- JRI N/A
- PACB $3.33
- Revenue Next Year
- JRI N/A
- PACB $18.52
- P/E Ratio
- JRI N/A
- PACB N/A
- Revenue Growth
- JRI N/A
- PACB N/A
- 52 Week Low
- JRI $9.70
- PACB $0.85
- 52 Week High
- JRI $12.12
- PACB $2.72
- Technical
- Relative Strength Index (RSI)
- JRI 73.58
- PACB 57.95
- Support Level
- JRI $12.91
- PACB $1.14
- Resistance Level
- JRI $13.14
- PACB $1.35
- Average True Range (ATR)
- JRI 0.12
- PACB 0.10
- MACD
- JRI 0.04
- PACB 0.00
- Stochastic Oscillator
- JRI 93.44
- PACB 60.71
About JRI Nuveen Real Asset Income and Growth Fund of Beneficial Interest
Nuveen Real Asset Income and Growth Fund is the United States-based closed-end fund. Its objective is to provide a high level of current income and long-term capital appreciation. The fund invests a majority of its managed assets in equity and debt securities issued by real asset related companies located anywhere in the world. Its strategy involves investments in five security types, infrastructure common stock, REIT preferred stock and debt securities. Real asset-related companies include those engaged in owning, operating, or developing infrastructure projects, facilities, and services, as well as REITs.
About PACB Pacific Biosciences of California Inc.
Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Asia-Pacific and Europe Middle East, and Africa.